NDUFB9

Across TCGA pan-cancer cohorts, NDUFB9 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated NDUFB9 data layer compared with 27 for mass-spec protein.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher NDUFB9 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated NDUFB9 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and HNSC show a favorable association.

CCRCC, HNSC, and UCEC are the cancer types where NDUFB9 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	All	0.857	0.614	.005	14	view →
HNSC	DFS	Median	All	0.860	0.361	.022	6	view →
UCEC	OS	Tertile	III,IV	0.802	0.539	.049	4	view →
LSCC	DFS	Quartile	II,III,IV	0.957	0.736	.035	3	view →
LUAD	OS	Median	II,III,IV	1.000	0.501	.022	2	view →
PDAC	DFS	Tertile	II,III,IV	0.428	0.653	.032	2	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

NDUFB9–CCRCC (DFS)

Open the CCRCC breakdown →